NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/12/2025
Back to search
Official data from USPTO
CEDRA PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CEDRA PHARMACY
ST13
US500000086382385Class
35
Filing
86382385
Registration
4839550
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
01/06/2026
Trademark type
Word
Nice classes
35
Filing date
09/02/2014
Registration date
10/27/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/12/2025
Last transaction
01/06/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
10/31/2013
First use in commerce
10/31/2013
Drawing code
4
Owner type
03
Owner location
Bronx, NY
Examiner
MARTIN,LIEF ANDREW
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Cedra Pharmacy Inc.
Representatives
Elizabeth A. Jaffe Golenbock Eiseman Assor Bell & Peskoe LLP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
retail store servicesretail pharmacyretail drug store and general consumer merchandise store services
Publications
History of USPTO decisions and trademark events.
25 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/12/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/12/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/12/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
09/03/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/28/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/13/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/13/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/13/2021
E815
TEAS SECTION 8 & 15 RECEIVED
09/13/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/08/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
10/27/2015
PUBO
PUBLISHED FOR OPPOSITION
08/11/2015
NPUB
NOTICE OF PUBLICATION
07/22/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/03/2015
ALIE
ASSIGNED TO LIE
07/01/2015
CNEA
EXAMINERS AMENDMENT MAILED
06/15/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/15/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
06/15/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/15/2015
CNRT
NON-FINAL ACTION MAILED
12/19/2014
CNRT
NON-FINAL ACTION WRITTEN
12/18/2014
DOCK
ASSIGNED TO EXAMINER
12/15/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/12/2014
NWAP
NEW APPLICATION ENTERED
09/05/2014
Continuous trademark protection
Get notified about every new filing that threatens CEDRA PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.